BamSEC and AlphaSense Join Forces
Learn More

Adamas Pharmaceuticals Inc

Formerly NASDAQ: ADMS
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 12 pages Adamas Pharmaceuticals, Inc. Restricted Stock Unit Grant Notice Performance Restricted Stock Unit
12/34/56
EX-10.1
from 10-Q 10 pages Adamas-Zydus Binding Term Sheet
12/34/56
EX-10.22
from 10-K 1 page Compensation Arrangements With Executive Officers
12/34/56
EX-10.19
from 10-K 11 pages Adamas Pharmaceuticals, Inc. Amended and Restated Executive Severance Plan
12/34/56
EX-10.6
from 10-K 16 pages Adamas Pharmaceuticals, Inc. 2016 Inducement Plan Adopted by the Board of Directors: March 4, 2016; as Amended: February 20, 2021 Termination Date: March 3, 2026
12/34/56
EX-10.2
from 10-Q 16 pages Adamas Pharmaceuticals, Inc. 2016 Inducement Plan Adopted by the Board of Directors: March 4, 2016; as Amended: October 2, 2020 Termination Date: March 3, 2026
12/34/56
EX-10.1
from 10-Q ~1 page July 15, 2020 via Hand Delivery Rajiv Patni C/O Adamas Pharmaceuticals, Inc. Re: Separation and Consulting Agreement Extension Dear Rajiv
12/34/56
EX-10.3
from 10-Q ~5 pages Non-Employee Director Compensation
12/34/56
EX-10.2
from 10-Q 8 pages February 20, 2020 via Hand Delivery Rajiv Patni C/O Adamas Pharmaceuticals, Inc. Re: Separation and Consulting Agreement Dear Rajiv: This Letter Sets Forth the Substance of the Separation and Consulting Agreement (The “Agreement”) That Adamas Pharmaceuticals, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition
12/34/56
EX-10.1
from 10-Q 8 pages January 9, 2020 via Hand Delivery Jennifer Rhodes C/O Adamas Pharmaceuticals, Inc. Re: Separation and Consulting Agreement Dear Jennifer: This Letter Sets Forth the Substance of the Separation and Consulting Agreement (The “Agreement”) That Adamas Pharmaceuticals, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition
12/34/56
EX-10.41
from 10-K 10 pages Adamas-Sandoz Binding Term Sheet
12/34/56
EX-10.6
from 10-K 16 pages Adamas Pharmaceuticals, Inc. 2016 Inducement Plan Adopted by the Board of Directors: March 4, 2016; as Amended: February 24, 2020 Termination Date: March 3, 2026
12/34/56
EX-10.3
from 10-Q 4 pages We Are Very Excited to Have You Join Adamas Pharmaceuticals, Inc. (The “Company”). in This Letter, I Would Like to Set Forth the Terms and Conditions of Your Employment Relationship With the Company
12/34/56
EX-10.2
from 10-Q 12 pages September 11, 2019 via Hand Delivery Greg Went C/O Adamas Pharmaceuticals, Inc. Re: Transition, Separation, and Consulting Agreement Dear Greg: This Letter Sets Forth the Substance of the Transition, Separation, and Consulting Agreement (The “Agreement”) That Adamas Pharmaceuticals, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition
12/34/56
EX-10.1
from 10-Q 9 pages August 7, 2019 Alfred Merriweather C/O Adamas Pharmaceuticals, Inc. Re: Separation and Consulting Agreement Dear Alf: This Letter Sets Forth the Substance of the Separation and Consulting Agreement (The “Agreement”) That Adamas Pharmaceuticals, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition
12/34/56
EX-10.3
from 10-Q 6 pages Amendment No. 1 to Amended and Restated Commercial Supply Agreement
12/34/56
EX-10.2
from 10-Q 4 pages We Are Very Excited to Have You Join Adamas Pharmaceuticals, Inc. (“The Company”). in This Letter, I Would Like to Set Forth the Terms and Conditions of Your Employment Relationship With the Company
12/34/56
EX-10.7
from 10-K 15 pages Adamas Pharmaceuticals, Inc. 2016 Inducement Plan Adopted by the Board of Directors: March 4, 2016; as Amended: March 1, 2019 Termination Date: March 3, 2026
12/34/56
EX-10.2
from 10-Q 27 pages September 13, 2018 via Hand Delivery Richard A. King C/O Adamas Pharmaceuticals, Inc. Re: Separation and Consulting Agreement Dear Richard: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Adamas Pharmaceuticals, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition
12/34/56
EX-10.1
from 10-Q 2 pages Eighth Amendment to Office Lease Agreement
12/34/56